Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Wass

Showing results (21-30 of 127) with videos related to

Pageof 13
Sort By:
European Journal of Endocrinology|February 9, 2007
What are the markers of aggressiveness in prolactinomas? Changes in cell biology, extracellular matrix components, angiogenesis and geneticsAlper Gürlek, Niki Karavitaki, Olaf Ansorge, et al.
European Journal of Endocrinology|December 3, 2014
Management of endocrine disease: pituitary tumour apoplexyCristina Capatina, Warrick Inder, Niki Karavitaki, et al.
Clinical Endocrinology|January 10, 2003
Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumours but do not recur more frequentlyK J Bradley, J A H Wass, H E Turner
Endocrine|November 29, 2005
Treatment of pituitary tumors: historyGaya Thanabalasingham, Niki Karavitaki, Simon Cudlip, et al.
Clinical Endocrinology|July 27, 2004
Systematic dose-extension of octreotide LAR: the importance of individual tailoring of treatment in patients with acromegalyHelen E Turner, Viv A Thornton-Jones, John A H Wass
Clinical Endocrinology|March 27, 2009
The value of the oral glucose tolerance test, random serum growth hormone and mean growth hormone levels in assessing the postoperative outcome of patients with acromegalyN Karavitaki, A Fernandez, V Fazal-Sanderson, et al.
Endocrine Reviews|March 18, 2006
CraniopharyngiomasNiki Karavitaki, Simon Cudlip, Christopher B T Adams, et al.
Pituitary|January 18, 2006
Angiogenesis in prolactinomas: regulation and relationship with tumour behaviourN Garcia de la Torre, H E Turner, J A H Wass
Endocrine-Related Cancer|June 7, 2003
Parathyroid adenomas and cardiovascular riskN Garcia de la Torre, J A H Wass, H E Turner
Frontiers of Hormone Research|July 30, 2004
Morphologic changes and molecular regulation of angiogenesis in pituitary adenomasN Garcia de la Torre, J A H Wass, H E Turner
Pageof 13

Showing results (21-30 of 127) with videos related to

Sort By:
Pageof 13
European Journal of Endocrinology|February 9, 2007
What are the markers of aggressiveness in prolactinomas? Changes in cell biology, extracellular matrix components, angiogenesis and geneticsAlper Gürlek, Niki Karavitaki, Olaf Ansorge, et al.
European Journal of Endocrinology|December 3, 2014
Management of endocrine disease: pituitary tumour apoplexyCristina Capatina, Warrick Inder, Niki Karavitaki, et al.
Clinical Endocrinology|January 10, 2003
Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumours but do not recur more frequentlyK J Bradley, J A H Wass, H E Turner
Endocrine|November 29, 2005
Treatment of pituitary tumors: historyGaya Thanabalasingham, Niki Karavitaki, Simon Cudlip, et al.
Clinical Endocrinology|July 27, 2004
Systematic dose-extension of octreotide LAR: the importance of individual tailoring of treatment in patients with acromegalyHelen E Turner, Viv A Thornton-Jones, John A H Wass
Clinical Endocrinology|March 27, 2009
The value of the oral glucose tolerance test, random serum growth hormone and mean growth hormone levels in assessing the postoperative outcome of patients with acromegalyN Karavitaki, A Fernandez, V Fazal-Sanderson, et al.
Endocrine Reviews|March 18, 2006
CraniopharyngiomasNiki Karavitaki, Simon Cudlip, Christopher B T Adams, et al.
Pituitary|January 18, 2006
Angiogenesis in prolactinomas: regulation and relationship with tumour behaviourN Garcia de la Torre, H E Turner, J A H Wass
Endocrine-Related Cancer|June 7, 2003
Parathyroid adenomas and cardiovascular riskN Garcia de la Torre, J A H Wass, H E Turner
Frontiers of Hormone Research|July 30, 2004
Morphologic changes and molecular regulation of angiogenesis in pituitary adenomasN Garcia de la Torre, J A H Wass, H E Turner
Pageof 13